Cargando…

Role of no reflow and microvascular obstruction in the prognostic stratification of STEMI patients

Effective reperfusion of ischemic myocardium is the final aim of both pharmacological and mechanical reperfusive strategies in patients with ST-segment elevation myocardial infarction. More effective reperfusion is related to better prognosis. In contrast, ineffective reperfusion (no reflow) has bee...

Descripción completa

Detalles Bibliográficos
Autor principal:	Durante, Alessandro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Kare Publishing 2018
Materias:	Invited Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6280267/ https://www.ncbi.nlm.nih.gov/pubmed/29537970 http://dx.doi.org/10.14744/AnatolJCardiol.2018.62343

Ejemplares similares

Predicting mortality and no‐reflow in STEMI patients using epicardial adipose tissue
por: Mohamed, Amr
Publicado: (2021)

No-Reflow after PPCI—A Predictor of Short-Term Outcomes in STEMI Patients
por: Pantea-Roșan, Larisa Renata, et al.
Publicado: (2020)

The SALINE Technique for the Treatment of the No-Reflow Phenomenon during Percutaneous Coronary Intervention in STEMI
por: Grancini, Luca, et al.
Publicado: (2023)

Clinical predictors of microvascular obstruction by delayed enhanced CMR in STEMI patients
por: Izquierdo, Maria M, et al.
Publicado: (2011)

Clinical predictors of microvascular obstruction by delayed enhanced CMR in STEMI patients
por: Pérez, José T Ortiz, et al.
Publicado: (2011)

The predictive value of eosinophil levels on no-reflow in patients with STEMI following PCI: a retrospective cohort study
por: Mo, De-Gang, et al.
Publicado: (2022)

Association of myocardial hemorrhage and persistent microvascular obstruction with circulating inflammatory biomarkers in STEMI patients
por: Bochaton, Thomas, et al.
Publicado: (2021)

Formation of Microvascular Networks: Role of Stromal Interactions Directing Angiogenic Growth
por: Hoying, James B, et al.
Publicado: (2014)

Simple clinical risk score for no-reflow prediction in patients undergoing primary Percutaneous Coronary Intervention with acute STEMI
por: Dogan, Nazile Bilgin, et al.
Publicado: (2015)

Plasma DPP4 activity is associated with no-reflow and major bleeding events in Chinese PCI-treated STEMI patients
por: Li, Jing Wei, et al.
Publicado: (2016)

In-Hospital Peak Glycemia in Predicting No-Reflow Phenomenon in Diabetic Patients with STEMI Treated with Primary Percutaneous Coronary Intervention
por: Liu, Fang, et al.
Publicado: (2021)

Inflammation and diabetic retinal microvascular complications
por: Zhang, Wenbo, et al.
Publicado: (2011)

Using an Artificial Neural Network to Predict Coronary Microvascular Obstruction (No-Reflow Phenomenon) during Percutaneous Coronary Interventions in Patients with Myocardial Infarction
por: Frolov, A.A., et al.
Publicado: (2021)

The role of endoscopy in malignant hilar obstruction
por: Dhar, Jahnvi, et al.
Publicado: (2023)

A fibrin targeted molecular imaging evaluation of microvascular no‐reflow in acute ischemic stroke
por: Chen, Xi, et al.
Publicado: (2022)

Synchrony of spontaneous Ca(2+) activity in microvascular mural cells
por: Mitsui, Retsu, et al.
Publicado: (2020)

Increase in the risk of clopidogrel resistance and consequent TIMI flow impairment by DNA hypomethylation of CYP2C19 gene in STEMI patients undergoing primary percutaneous coronary intervention (PPCI)
por: Sukmawan, Renan, et al.
Publicado: (2021)

Myocardial Salvage is Reduced in Primary PCI-Treated STEMI Patients with Microvascular Obstruction, Demonstrated by Early and Late CMR
por: Limalanathan, Shanmuganathan, et al.
Publicado: (2013)

Microvascular Obstruction Evaluation Using Cardiovascular Magnetic Resonance (CMR) in ST-Elevated Myocardial Infarction (STEMI) Patients
por: Piotrowska-Kownacka, Dorota, et al.
Publicado: (2015)

Malignant biliary obstruction: the current role of interventional radiology
por: Tsetis, Dimitrios, et al.
Publicado: (2016)

Predilation Ballooning in High Thrombus Laden STEMIs: An Independent Predictor of Slow Flow/No-Reflow in Patients Undergoing Emergent Percutaneous Coronary Revascularization
por: Kumar, Rajesh, et al.
Publicado: (2023)

Methods to label, image, and analyze the complex structural architectures of microvascular networks
por: Corliss, Bruce A., et al.
Publicado: (2019)

“No-Reflow” Phenomenon: A Contemporary Review
por: Annibali, Gianmarco, et al.
Publicado: (2022)

Current state of risk stratification for sudden cardiac death in adults with congenital heart disease
por: Vehmeijer, Jim T., et al.
Publicado: (2018)

Aspirin for primary prevention of cardiovascular disease: Advice for a decisional strategy based on risk stratification
por: Aimo, Alberto, et al.
Publicado: (2020)

Comparison of angiographic results and clinical outcomes of no-reflow after stenting in left anterior descending (LAD) versus non-LAD culprit STEMI
por: Khan, Kamran Ahmed, et al.
Publicado: (2022)

No-Reflow Phenomenon and Endothelial Glycocalyx of Microcirculation
por: Maksimenko, Alexander V., et al.
Publicado: (2012)

Prophylactically injection of Nicorandil to reduce no-reflow phenomenon during PCI in acute STEMI patients: Protocol of a double-blinded, randomized, placebo-controlled trial
por: An, Su, et al.
Publicado: (2021)

Comparison of Diagnostic Value Between STE+LDDSE and CMR-FT for Evaluating Coronary Microvascular Obstruction in Post-PCI Patients for STEMI
por: Liu, Tao, et al.
Publicado: (2022)

Prognostic significance of severe coronary microvascular dysfunction post-PCI in patients with STEMI: A systematic review and meta-analysis
por: Canu, Marjorie, et al.
Publicado: (2022)

Patient stratification and genomics: flares, fizzlers and foxes
por: Smith, Kenneth GC
Publicado: (2012)

Performance of Radiomics in Microvascular Invasion Risk Stratification and Prognostic Assessment in Hepatocellular Carcinoma: A Meta-Analysis
por: Bodard, Sylvain, et al.
Publicado: (2023)

A Randomized Trial of Deferred Stenting Versus Immediate Stenting to Prevent No- or Slow-Reflow in Acute ST-Segment Elevation Myocardial Infarction (DEFER-STEMI)
por: Carrick, David, et al.
Publicado: (2014)

Early risk stratification using Rubidium-82 positron emission tomography in STEMI patients
por: Ghotbi, Adam Ali, et al.
Publicado: (2017)

Lipidomic Predictors of Coronary No-Reflow
por: Surendran, Arun, et al.
Publicado: (2023)

Usefulness of echocardiographic myocardial work in evaluating the microvascular perfusion in STEMI patients after revascularization
por: Jin, Wenying, et al.
Publicado: (2022)

Utilizing enoxaparin in the management of STEMI
por: Rubboli, Andrea, et al.
Publicado: (2007)

Microvascular obstruction persistence after early-reperfused myocardium infarction by CMR: analysis of first week and six months after STEMI
por: Oliveira, Amarino C, et al.
Publicado: (2011)

Advances in the endoscopic management of malignant biliary obstruction
por: Thomaidis, Thomas, et al.
Publicado: (2020)

Mechanisms of the “No-Reflow” Phenomenon After Acute Myocardial Infarction: Potential Role of Pericytes
por: Kaul, Sanjiv, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1873q9rb0tp2ohfareiub3i4b7